Key facts
- Notable investors include BoxGroup, Abstract Ventures, Lowercarbon Capital, A*, Solari Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for General Biological
- ·The full record, as it builds
Funding rounds
No funding rounds for General Biological are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About General Biological
Developer of sustainable bioproduction technology designed to replace petrochemical-based materials with bio-based alternatives. The company utilizes continuous manufacturing, renewable carbon utilization, and scalable bioreactors to produce high-performance materials, electronics components, and industrial solutions, enabling industries to transition toward environmentally responsible and cost-effective production methods.
- Sector
- Materials and Resources
- HQ
- New Haven, CT, United States
- Founded
- 2023
- Employees
- 10
- Website
- generalbiological.com/
- Ownership
- Privately Held (backing)
General Biological doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in General Biological shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on General Biological in its N-PORT filings yet. We sweep new filings monthly.